Fuad Baroody to Rhinitis, Allergic, Seasonal
This is a "connection" page, showing publications Fuad Baroody has written about Rhinitis, Allergic, Seasonal.
Connection Strength
4.955
-
Effect of intranasal fluticasone furoate and intraocular olopatadine on nasal and ocular allergen-induced symptoms. Am J Rhinol Allergy. 2013 Jan; 27(1):48-53.
Score: 0.363
-
Evidence of maxillary sinus inflammation in seasonal allergic rhinitis. Otolaryngol Head Neck Surg. 2012 Jun; 146(6):880-6.
Score: 0.341
-
Fluticasone furoate nasal spray reduces the nasal-ocular reflex: a mechanism for the efficacy of topical steroids in controlling allergic eye symptoms. J Allergy Clin Immunol. 2009 Jun; 123(6):1342-8.
Score: 0.282
-
Nasal challenge with allergen leads to maxillary sinus inflammation. J Allergy Clin Immunol. 2008 May; 121(5):1126-1132.e7.
Score: 0.261
-
Nasal ocular reflexes and eye symptoms in patients with allergic rhinitis. Ann Allergy Asthma Immunol. 2008 Mar; 100(3):194-9.
Score: 0.260
-
Elucidating the mechanism underlying the ocular symptoms associated with allergic rhinitis. Allergy Asthma Proc. 2008 Jan-Feb; 29(1):24-8.
Score: 0.257
-
Comparison of montelukast and pseudoephedrine in the treatment of allergic rhinitis. Arch Otolaryngol Head Neck Surg. 2006 Feb; 132(2):164-72.
Score: 0.225
-
Comparison of the combinations of fexofenadine-pseudoephedrine and loratadine-montelukast in the treatment of seasonal allergic rhinitis. Ann Allergy Asthma Immunol. 2004 Jan; 92(1):73-9.
Score: 0.194
-
Relationships between atopy and bacterial infections. Curr Allergy Asthma Rep. 2003 May; 3(3):232-7.
Score: 0.186
-
Allergic rhinitis: broader disease effects and implications for management. Otolaryngol Head Neck Surg. 2003 May; 128(5):616-31.
Score: 0.186
-
Fluticasone nasal spray and the combination of loratadine and montelukast in seasonal allergic rhinitis. Arch Otolaryngol Head Neck Surg. 2003 May; 129(5):557-62.
Score: 0.186
-
Effects of intranasal azelastine on the response to nasal allergen challenge. Laryngoscope. 2002 Jan; 112(1):47-52.
Score: 0.169
-
Absence of nasal mucosal atrophy with fluticasone aqueous nasal spray. Arch Otolaryngol Head Neck Surg. 2001 Feb; 127(2):193-9.
Score: 0.159
-
Hot, humid air partially inhibits the nasal response to allergen provocation. Arch Otolaryngol Head Neck Surg. 2000 Jun; 126(6):749-54.
Score: 0.152
-
Intranasal beclomethasone reduces allergen-induced symptoms and superficial mucosal eosinophilia without affecting submucosal inflammation. Am J Respir Crit Care Med. 1998 Mar; 157(3 Pt 1):899-906.
Score: 0.130
-
Treatment of seasonal allergic rhinitis: An evidence-based focused 2017 guideline update. Ann Allergy Asthma Immunol. 2017 12; 119(6):489-511.e41.
Score: 0.127
-
Low dose clemastine inhibits sneezing and rhinorrhea during the early nasal allergic reaction. Ann Allergy Asthma Immunol. 1997 Mar; 78(3):307-12.
Score: 0.121
-
Ragweed allergic rhinitis and the paranasal sinuses. A computed tomographic study. Arch Otolaryngol Head Neck Surg. 1997 Feb; 123(2):193-6.
Score: 0.120
-
A clinical trial of a microcrystalline cellulose topical nasal spray on the acute response to allergen challenge. Am J Rhinol Allergy. 2016 Jul; 30(4):269-73.
Score: 0.116
-
Observations on the response of the nasal mucosa to allergens. Otolaryngol Head Neck Surg. 1994 Sep; 111(3 Pt 2):355-63.
Score: 0.102
-
Seasonal allergic rhinitis affects sinonasal microbiota. Am J Rhinol Allergy. 2014 Jul-Aug; 28(4):281-6.
Score: 0.101
-
Physiologic responses and histamine release after nasal antigen challenge. Effect of atropine. Am J Respir Crit Care Med. 1994 Jun; 149(6):1457-65.
Score: 0.100
-
Allergic rhinitis. J Med Liban. 1994; 42(4):171-83.
Score: 0.097
-
Unilateral nasal allergic reactions increase bilateral sinus eosinophil infiltration. J Appl Physiol (1985). 2013 Nov 01; 115(9):1262-7.
Score: 0.095
-
Epigenetic modifications and improved regulatory T-cell function in subjects undergoing dual sublingual immunotherapy. J Allergy Clin Immunol. 2012 Jul; 130(1):215-24.e7.
Score: 0.087
-
Recruitment factors which affect the outcome of a seasonal allergic rhinitis trial. Allergy Asthma Proc. 2011 Jan-Feb; 32(1):55-63.
Score: 0.079
-
Olfactory cleft inflammation is present in seasonal allergic rhinitis and is reduced with intranasal steroids. Am J Rhinol Allergy. 2010 Jul-Aug; 24(4):286-90.
Score: 0.076
-
Effects of fexofenadine on the early response to nasal allergen challenge. Ann Allergy Asthma Immunol. 2002 Dec; 89(6):578-84.
Score: 0.045
-
Superiority of an intranasal corticosteroid compared with an oral antihistamine in the as-needed treatment of seasonal allergic rhinitis. Arch Intern Med. 2001 Nov 26; 161(21):2581-7.
Score: 0.042
-
Natural and induced allergic responses increase the ability of the nose to warm and humidify air. J Allergy Clin Immunol. 2000 Dec; 106(6):1045-52.
Score: 0.039
-
As-needed use of fluticasone propionate nasal spray reduces symptoms of seasonal allergic rhinitis. J Allergy Clin Immunol. 2000 Apr; 105(4):732-8.
Score: 0.037
-
Treatment with hot, humid air reduces the nasal response to allergen challenge. J Allergy Clin Immunol. 1997 Jan; 99(1 Pt 1):77-86.
Score: 0.030
-
Effect of enantiomeric forms of albuterol on stimulated secretion of granular protein from human eosinophils. Pulm Pharmacol Ther. 1997; 10(2):97-104.
Score: 0.030
-
Basophils and eosinophils in allergic rhinitis. J Allergy Clin Immunol. 1994 Dec; 94(6 Pt 2):1303-9.
Score: 0.026
-
Nasal allergen challenge generates 1-0-hexadecyl-2-lyso-sn-glycero-3-phosphocholine. Am J Respir Crit Care Med. 1994 Mar; 149(3 Pt 1):660-6.
Score: 0.025
-
Intranasal steroids inhibit seasonal increases in ragweed-specific immunoglobulin E antibodies. J Allergy Clin Immunol. 1993 Nov; 92(5):717-21.
Score: 0.024
-
The impact of immunotherapy on the pathophysiology of ragweed pollen allergy. Rhinol Suppl. 1992; 14:52-6.
Score: 0.021
-
Topical intranasal ioxaglate meglumine 39.3% and ioxaglate sodium 19.6% (Hexabrix) reduces the acute response to nasal challenge with allergen. J Allergy Clin Immunol. 2011 Jul; 128(1):219-21.
Score: 0.020
-
Hot, humid air increases cellular influx during the late-phase response to nasal challenge with antigen. Clin Exp Allergy. 2001 Dec; 31(12):1913-22.
Score: 0.011
-
The nasal passage of subjects with asthma has a decreased ability to warm and humidify inspired air. Am J Respir Crit Care Med. 2001 Nov 01; 164(9):1640-6.
Score: 0.010
-
Warming of feet elevates nasal mucosal surface temperature and reduces the early response to nasal challenge with allergen. J Allergy Clin Immunol. 1999 Aug; 104(2 Pt 1):285-93.
Score: 0.009
-
A technique to measure the ability of the human nose to warm and humidify air. J Appl Physiol (1985). 1999 Jul; 87(1):400-6.
Score: 0.009
-
Nasal provocation with allergen induces a secondary serum IgE antibody response. J Allergy Clin Immunol. 1997 Oct; 100(4):505-10.
Score: 0.008